Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

The diabetes market is booming, and Thermo Fisher Scientific is seizing the opportunity, positioning itself as a leader in ...

The diabetes market is booming, with continuous glucose monitoring (CGM) and GLP-1 drugs leading the charge in innovation and ...

Check your alert settings and refer to your device's manual to ensure the alerts are working as expected. Some people who use continuous glucose monitors have reported not receiving or hearing safety ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

Data from a controlled trial indicates that patients who switched from daily insulin injections to its Omnipod 5 automated ...

The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this. Whatever happens, though ...

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked ...

The overwhelming consensus amongst scientists is that there’s very little evidence to suggest that tracking your blood ...

Sequel Med Tech has announced that Abbott’s FreeStyle Libre 3 Plus sensor will be the first continuous glucose monitoring device to work with its twiist Automated Insulin Delivery (AID) System powered ...

Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...